Abiopharma

CapitaLand Retail China Trust is a Singapore-based real estate investment trust ("REIT") constituted with the investment objective of investing on a long term basis in real estate used primarily for retail purposes and located primarily in China, Hong Kong and Macau.

Additional info from SGX:

CapitaLand China Trust (CLCT) is Singapores largest China-focused real estate investment trust (REIT) that is listed on Singapore Exchange Securities Trading Limited (SGX-ST) with a market capitalisation of S$2.1 billion as at 31 March 2021. CLCT was first listed on the SGX on 8 December 2006 as CapitaLand Retail China Trust (CRCT), and was renamed to CLCT in 26 January 2021 following the expansion in investment mandate in 2020. CLCT is established with the objective of investing on a long-term basis in a diversified portfolio of income-producing real estate and real estate-related assets in China, Hong Kong and Macau that are used primarily for retail, office and industrial purposes (including business parks, logistics facilities, data centres and integrated developments). Positioned as a proxy for growth to Chinas future economy, CLCTs portfolio constitutes 11 shopping malls and five business parks. The geographically diversified portfolio has a total gross floor area (GFA) of approximately 1.7 million square metre (sq m) that is located across 10 leading Chinese cities.
CLCT is managed by CapitaLand China Trust Management Limited, a wholly owned subsidiary of Singapore-listed CapitaLand Limited, one of Asias largest diversified real estate group.

Additional info from OTC:
CapitaLand Retail China Trust is a Singapore-based real estate investment trust ("REIT") constituted with the investment objective of investing on a long term basis in real estate used primarily for retail purposes and located primarily in China, Hong Kong and Macau.